Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis - 21/08/11
Paul Yamauchi, MD, PhD, Nicolas Lowe, MD, Clinical Research Specialists, Santa Monica, CA, United States; Supin Koo, PhD, Amgen, Thousand Oaks, CA, United States
Le texte complet de cet article est disponible en PDF. P3 Dr. Yamauchi is a consultant, principal investigator, and speaker for Amgen but has no proprietary interest in the company. Dr. Lowe is a member of the Speakers Bureau for Amgen. Dr. Koo is an employee of Amgen. Writing support and poster production provided by Immunex Corporation, a wholly owned subsidiary of Amgen Inc., and by Wyeth Research. |
Vol 52 - N° 3S
P. P1 - mars 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?